Program I status unquestionably raises the volume of complexity for any investigate review. By way of example, all scientists—regardless of whether preclinical or scientific—ought to acquire Agenda I exploration registrations. 21 CFR section 1301.18. Against this, scientists who may have DEA Practitioner registrations in Schedules II–V (which